OvaPrene

Product Overview

Delivery Type: ,

Description: A non-hormonal intravaginal contraceptive ring, which is one-size-fits-all, made from silicone, serves as a barrier, and is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.

Updated date: May 30, 2018

Vertical Tabs

Status

Status Details:
  • Phase II trial was reported completed in 2010. A Phase 1 safety-and-tolerability study concluded that "the Ovaprene device is well-tolerated and acceptable to sexually active women and their partners."
  • Daré intends to begin a PCT clinical trial of Ovaprene® in early 2018, with projected completion within the next 2 years.

Download Product Report